Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

Eric Bruckert Articles

PlayODYSSEY 78 week HeFH data: Clinical perspectives

ODYSSEY 78 week HeFH data: Clinical perspectives

PCSK9 monoclonal antibody therapy has been shown to be highly efficacious in patients with heterozygous familial hypercholesterolaemia (FH, inherited high cholesterol). However, as patients will require treatment in the long-term, efficacy and safety data are needed. The recent publication of 78 week data from the…

read more »
FH in the statin era: we need to do better

FH in the statin era: we need to do better

Despite the availability of generic statin therapy, cardiovascular disease accounts for 50% of all deaths in FH patients. Clinicians need to do better, argues Eric Bruckert, Institut E3M et IHU cardiométabolique (ICAN), Hôpital Pitié Salpêtrière, Paris, France. Familial hypercholesterolemia (FH) is a severe condition, which…

read more »